12/18/2024
8:30 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 8-K/A | |
11/21/2024
8:15 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:15 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:15 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
8:25 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
3:29 PM | Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Toh Kean Meng Melvin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/17/2024
3:30 PM | Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Yu Ying Choi Alan Abel (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/17/2024
3:29 PM | CK Life Sciences Intl Inc (0001297567) (Reporting)
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Sealbond Ltd (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/15/2024
3:19 PM | Sealbond Ltd (Filed by)
Virios Therapeutics (Subject)
Virios Therapeutics, Inc. (Subject)
| Form SC 13D | |
10/07/2024
7:06 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form DEFA14A | |
10/07/2024
7:02 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for VIRI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
08/09/2024
9:15 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
8:30 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
8:15 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2024
8:15 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
8:28 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
9:30 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
7:01 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
4:25 PM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
4:26 PM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form ARS | |
04/25/2024
3:33 PM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form DEF 14A | |
03/01/2024
8:10 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/29/2024
8:25 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
11:43 AM | Gendreau Roger Michael (Reporting)
Virios Therapeutics (Issuer)
Virios Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
11:47 AM | Grosswald Ralph (Reporting)
Virios Therapeutics (Issuer)
Virios Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
11:51 AM | Virios Therapeutics (Issuer)
Virios Therapeutics, Inc. (Issuer)
Walsh Angela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
11:54 AM | De La Rosa Abel (Reporting)
Virios Therapeutics (Issuer)
Virios Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
11:40 AM | Duncan Gregory Scott (Reporting)
Virios Therapeutics (Issuer)
Virios Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
3:21 PM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form DEFA14A | |
Free VIRI Stock Alerts